Drug
PDCD5 protein, rat clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 4
- first study started
- 2009
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2014 (4)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses PDCD5 protein, rat is read from its arms, and is right about nine times in ten.
Testing it · 6
- AM-101 in the Treatment of Acute Tinnitus 3CompletedPhase 3Auris Medical AGNCT02040194Written as AM-101
- AM-101 in the Treatment of Post-Acute Tinnitus 2CompletedPhase 3Auris Medical AGNCT02040207Written as AM-101
- AM-101 in the Treatment of Acute Tinnitus 2CompletedPhase 3Auris Medical, Inc.NCT01803646Written as AM-101
- AM-101 in the Treatment of Post-Acute Tinnitus 1CompletedPhase 3Auris Medical, Inc.NCT01934010Written as AM-101
- Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear TinnitusCompletedPhase 2Auris Medical, Inc.NCT01270282Written as AM-101 0.81 mg/mL
- Efficacy of AM 101 in Patients With Acute Inner Ear TinnitusCompletedPhase 2Auris Medical AGNCT00860808Written as AM-101